BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.040
-0.270 (-8.16%)
At close: Oct 30, 2026, 4:00 PM EST
3.100
+0.060 (1.97%)
Pre-market: Nov 2, 2026, 7:00 AM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $26.81 million as of October 30, 2026. Its market cap has increased by 14.58% in one year.
Market Cap
26.81M
Enterprise Value
5.31M
1-Year Change
14.58%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $26.81M, an increase of 3.12%. That is a compound annual growth rate of 0.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 26.50M | 97.76% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Metagenomi Therapeutics | 29.48M |
| NextCure | 28.88M |
| Estrella Immunopharma | 27.81M |
| TransCode Therapeutics | 27.60M |
| BeyondSpring | 26.47M |
| Polyrizon | 26.11M |
| ABVC BioPharma | 25.96M |
| Celularity | 25.96M |